CSDC — A nationwide screening platform for stroke control and prevention in China
暂无分享,去创建一个
Dan Ye | Mei Li | Huajian Mao | Dongsheng Zhao | Jinghui Yu | Dongsheng Zhao | D. Ye | Mei Li | Huajian Mao | Jinghui Yu
[1] Dong Zhao,et al. Epidemiological Transition of Stroke in China: Twenty-One–Year Observational Study From the Sino-MONICA-Beijing Project , 2008, Stroke.
[2] Eric E. Smith,et al. Temporal Trends in Patient Characteristics and Treatment With Intravenous Thrombolysis Among Acute Ischemic Stroke Patients at Get With the Guidelines–Stroke Hospitals , 2013, Circulation. Cardiovascular quality and outcomes.
[3] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[4] E. Halperin,et al. Presymptomatic Risk Assessment for Chronic Non-Communicable Diseases , 2010, PloS one.
[5] N. Sims,et al. Mitochondria, oxidative metabolism and cell death in stroke. , 2010, Biochimica et biophysica acta.
[6] Jinlei Li,et al. Prevalence of stroke in China: an epidemiological study based on the National Stroke Screening Survey , 2015, The Lancet.